o2h Ventures (o2h) is a Venture Capital Group investing into early stage Biotech companies based in the UK. Through sister companies o2h Discovery and o2h Co-Work it has built a world class ecosystem to source, support, and find business opportunities for many of these companies. The funds have invested into over 30 companies, many of which were university spinouts from including Tay Pharmaceuticals, Dundee Uni; PharmEnable, Cambridge Uni, and Exonate, Nottingham Uni. For a full list of our portfolio companies see: https://o2hventures.com/portfolio. The sweet spot of the fund is to invest in novel biotech therapeutics or technologies such as AI and Machine learning that can enable this.